SEC Alleges $74M Fraud in Sales of SpaceX, Anthropic Private Shares
The SEC alleges that Andrew Spaventa and The Spaventa Group ran a boiler room operation that raised $74 million from retail investors through undisclosed markups.
The Securities and Exchange Commission has filed charges against New York financier Andrew Spaventa and his firm, The Spaventa Group, alleging a $74 million fraud scheme targeting retail investors and retirees. According to Fortune, a sales force of more than 100 agents allegedly used high-pressure, scripted cold-calls to pitch shares in exclusive private technology companies such as SpaceX, Anduril, Anthropic, and Perplexity.
Over four and a half years from December 2020 to June 2025, the operation reportedly raised more than $74 million across 11 private funds from over 800 buyers. The SEC noted that most participants were retail investors, including more than 650 who invested $100,000 or less and over 100 retirees.
Regulators state that despite promises of no hidden fees, investors paid an average of 46% more for their positions than Spaventa's own companies paid to acquire them, with some markups reaching as high as 91%. The complaint alleges that Spaventa and his entities collected $23 million in undisclosed fees.
Of the collected fees, more than $12 million reportedly went toward commissions for the sales agents, while Spaventa personally received at least $4 million. The SEC states that Spaventa used these funds for a home purchase, renovations, personal travel, and luxury car payments.
The regulatory complaint outlines specific transactions, noting that Fund 8 held Anthropic shares acquired at prices between $32.62 and $41.53 but sold to the fund at $58.50. Similarly, funds holding Perplexity AI bought shares between $340.72 and $389 and resold them at $495, while SpaceX and Anduril positions also carried substantial markups.
The SEC claims that Spaventa was the sole owner of the entities selling the shares to the funds, as well as the entities managing and advising the funds. Without a board of directors or third-party evaluations, these transactions allegedly lacked arm's length oversight, and Spaventa reportedly failed to obtain required written client consent.
Reached by phone, the 40-year-old Spaventa denied the allegations in the complaint and stated his intention to defend himself against the SEC's charges. None of the startup companies whose shares were traded are accused of wrongdoing, and the SEC is currently seeking disgorgement, civil penalties, and permanent industry bars.